# Smokers or non-smokers: who benefits more from immune checkpoint inhibitors in treatment of malignancies? An up-to-date meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/smokers-or-non-smokers-who-benefits-more-from-immune-checkpoint-inhibitors-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jiahang Mo,Xiao Hu,Lihu Gu,Bangsheng Chen,Parikshit Asutosh Khadaroo,Zefeng Shen,Lei Dong,Yuqi Lv,Marylin Nyaradzo Chitumba,Jiequan Liu |
| Citations | 98 |
| DOI | 10.1186/s12957-020-1792-4 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://wjso.biomedcentral.com/track/pdf/10.1186/s12957-020-1792-4 |
| OpenAlex ID | https://openalex.org/W3002314881 |
| PMID | 31959178 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Bangsheng Chen](https://scholariq.org/researchers/bangsheng-chen/)

## Paper journal

- [World Journal of Surgical Oncology](https://scholariq.org/journals/world-journal-of-surgical-oncology/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.